Pfizer halts India

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Pfizer suspended Premarin vaginal cream sales in India due to supply challenges, impacting millions of women needing estrogen therapy. The product accounted for 37% of India's conjugated estrogen mark